Since the first successful birth in 1978 following in vitro fertilisation (IVF), this has become established treatment for infertility and is available at more than thirty centres in the United Kingdom. Oocyte donation has extended the use of IVF technology for conditions where a genetic abnormality exists or where repeated attempts at IVF have failed to achieve fertilisation. In cases where the ovaries are absent or have failed prematurely, the procedure can be combined with steroid replacement therapy to maintain a successful pregnancy. Donated oocytes have been obtained from relatives and friends, but more recently it has been recommended that the donor should remain anonymous. The following case report is of the first such pregnancy achieved in Northern Ireland.
CASE REPORT
A 25-year -old married woman presented to the infertility clinic, Royal Maternity Hospital, Belfast, in 1986, complaining of secondary amenorrhoea. Investigations had been undertaken at the age of 21 and had revealed elevated serum gonadotrophins in keeping with a diagnosis of premature ovarian failure. The chromosome complement was that of a normal female. Hormone replacement therapy with conjugated oestrogens 0-625mg and norgestrel 0-15mg (Prempak -C, Ayerst) was commenced. The possibility of pregnancy achieved by IVF using a donated ovum was discussed, and it was advised that an anonymous arrangement would be preferable. The patient remained on hormone replacement therapy until October 1987 when an IVF programme commenced in Northern Ireland. Hormone therapy was then altered to a maintenance dose of oral oestradiol valerate (Progynova, Schering) 2 mg daily until a potential donor became available. A random serum oestradiol was 2509 pmol/l on this regimen. The dose was increased to 4mg daily shortly after a potential donor, who was undergoing gamete intrafallopian transfer (GIFT) had commenced superovulation therapy. Eight oocytes were obtained from the donor by laparoscopy, four of which were replaced in her fallopian tubes with capacitated spermatozoa from her husband. The remaining four oocytes were transferred to prepared culture dishes containing Earle's balanced salt solution with 10% human serum. A sample of the recipient's husband's semen was prepared by a centrifugation and swim-up technique, which enables the motile sperm to be extracted. Four hours later 100,000 sperm were added to each of the dishes containing an individual oocyte, and after 18 hours three oocytes had developed two pronuclei, which confirmed that fertilisation had occurred. At this time the patient was asked to increase her oestradiol valerate to 6mg daily and was also given progesterone 50mg (Gestone, Paines & Byrne) by intramuscular injection. This was repeated the following day to coincide with embryo transfer, at which time serum oestradiol was 2591 pmol/l and progesterone was 32 -2 nmol/l, both of these levels being within the normal range. Forty -eight hours after insemination two of the three embryos had divided normally. Embryo transfer was carried out under aseptic conditions, with the patient in the lithotomy position, using a fine plastic catheter which was inserted through the cervical os. The two embryos were placed in the recipient's uterus in 3 p1 of medium with the added human serum concentration increased to 75 %. Hormone maintenance therapy was provided by oestradiol valerate 4mg and progesterone 50mg daily, and the serum levels of these two hormones checked twice weekly; all values initially followed the normal curve.' Fifteen days after embryo transfer a pregnancy test was positive, and at 40 days a fetal circulation was identified with ultrasound. During the fourth week of pregnancy the progesterone levels fell below the optimal range (Figure) , so the dose of progesterone was increased to 100mg daily. At six and eight weeks the 
